Fecal microbiota transplantation in patients with metabolic syndrome and obesity: A randomized controlled trial

BACKGROUND: Metabolic syndrome is a multifactorial disease, and the gut microbiota may play a role in its pathogenesis. Obesity, especially abdominal obesity, is associated with insulin resistance, often increasing the risk of type two diabetes mellitus, vascular endothelial dysfunction, an abnormal...

Descripción completa

Detalles Bibliográficos
Autores principales: da Ponte Neto, Alberto Machado, Clemente, Aniele Cristine Ott, Rosa, Paula Waki, Ribeiro, Igor Braga, Funari, Mateus Pereira, Nunes, Gabriel Cairo, Moreira, Luana, Sparvoli, Luiz Gustavo, Cortez, Ramon, Taddei, Carla Romano, Mancini, Márcio C, de Moura, Eduardo Guimarães Hourneaux
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Randomized Controlled Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353513/
https://www.ncbi.nlm.nih.gov/pubmed/37469721
http://dx.doi.org/10.12998/wjcc.v11.i19.4612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10353513/
https://www.ncbi.nlm.nih.gov/pubmed/37469721
http://dx.doi.org/10.12998/wjcc.v11.i19.4612

Ejemplares similares